Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Contribution of Inflammation and Insulin Resistance to Intermittent Claudication

NCT00153166 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT00153166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00153166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Contribution of Inflammation and Insulin Resistance to Intermittent Claudication
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2004
Completion date
December 31, 2011
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive disease, insulin resistance, intermittent claudication